|
|||||
|
|
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator |
|
| Authors: | Jonas M. den Heijer MD PhD Annelieke C. Kruithof PhD Matthijs Moerland PhD Mike Walker MSc Lindsay Dudgeon MSc Craig Justman PhD Imelda Solomini BS Leslie Splitalny MSc Nancy Leymarie PhD Kshitij Khatri PhD Valerie C. Cullen PhD Dana C. Hilt MD Geert Jan Groeneveld MD PhD Peter Lansbury PhD |
| Affiliation: | 1. Department of Neurology, Centre for Human Drug Research, Leiden, the Netherlands;2. Department of Neurology, Centre for Human Drug Research, Leiden, the Netherlands Leiden University Medical Centre, Leiden, the Netherlands;3. Certara, QSP, Canterbury, United Kingdom;4. Lysosomal Therapeutics Inc., Cambridge, Massachusetts, USA |
| Abstract: | |
| Keywords: | glucosylceramidase beta clinical trial disease modification genetic parkinsonism |